Aspirin Resistance * Aspirin Resistance * Response
نویسندگان
چکیده
منابع مشابه
Aspirin Resistance
The development of adverse cardiovascular events despite aspirin use has established an interest in a possible resistance to the drug. Several definitions have been set and various laboratory testing modalities are available. This has led to a wide range of prevalence reports in different clinical entities. The etiologic mechanism has been related to clinical, genetic, and other miscellaneous f...
متن کاملAspirin Resistance
To the Editor: Aspirin resistance is a poorly defined term and could involve the clinical inability of aspirin to protect individuals from arterial thrombotic events or laboratory methods indicating the failure of aspirin to inhibit platelet activity, mainly platelet aggregation. Indeed, resistance to aspirin may be associated with an increase of arterial thrombotic events in spite of chronic a...
متن کاملAspirin resistance.
Aspirin protects many though not all patients from acute cardiovascular events. It is generally accepted that such prophylactic effect depends mainly on the antithrombotic action involving inhibition of thromboxane A(2) production and platelet aggregation. In many patients aspirin failure to protect against cardiovascular event is obvious, as their symptoms simply cannot be controlled by the ad...
متن کاملAspirin resistance.
To the Editor: Aspirin resistance is a poorly defined term and could involve the clinical inability of aspirin to protect individuals from arterial thrombotic events or laboratory methods indicating the failure of aspirin to inhibit platelet activity, mainly platelet aggregation. Indeed, resistance to aspirin may be associated with an increase of arterial thrombotic events in spite of chronic a...
متن کاملDiabetes and Aspirin Resistance
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in patients with diabetes mellitus (DM). DM is considered as a coronary artery disease equivalent for future risk of vascular events. There are 3 different classes of platelet-inhibiting drugs: cyclooxygenase-1 (COX-1) inhibitors (aspirin), ADP P2Y12 receptor antagonists (thienopyridines), and platelet glycoprotein (GP...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Circulation
سال: 2002
ISSN: 0009-7322,1524-4539
DOI: 10.1161/01.cir.0000041810.21243.db